Over long durations, a higher concentration of hormones may be required to overcome physiological ancillary impacts
Additionally, lixisenatide is not the only GLP-1 receptor agonist with potential therapeutic applications for Parkinson's at least six other similar medications are currently being evaluated as a potential PD treatment
While most prominent in the US, they have now reached Europe
Patients shouldnt stop treatment because theyre worried about hair loss alone
Creation and maintenance of GLP-1RA audit rules The information pharmacists create GLP-1RA drug audit rules in combination with the actual situation of the hospital, including standardization of indications, dosage, medication for special populations, special pathological states, co-medication, interactions, and other audit judgment criteria, in order to warn the patients of prudent use, prohibited use, and ADEs